NeuroOne Medical Technologies Management
Management criteria checks 3/4
NeuroOne Medical Technologies' CEO is Dave Rosa, appointed in Jul 2017, has a tenure of 6.83 years. total yearly compensation is $989.56K, comprised of 51.2% salary and 48.8% bonuses, including company stock and options. directly owns 1.56% of the company’s shares, worth $455.96K. The average tenure of the management team and the board of directors is 4.2 years and 6.2 years respectively.
Key information
Dave Rosa
Chief executive officer
US$989.6k
Total compensation
| CEO salary percentage | 51.2% |
| CEO tenure | 6.8yrs |
| CEO ownership | 1.6% |
| Management average tenure | 4.2yrs |
| Board average tenure | 6.2yrs |
Recent management updates
Recent updates
Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?
Dec 16
Can NeuroOne Medical Technologies (NASDAQ:NMTC) Afford To Invest In Growth?
Jul 25Here's Why We're Watching NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Situation
Apr 11We Think NeuroOne Medical Technologies (NASDAQ:NMTC) Needs To Drive Business Growth Carefully
Sep 15NeuroOne rallies on receiving $3.5M in accelerated milestone payment from Zimmer Biomet
Aug 03Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?
Jun 02Companies Like NeuroOne Medical Technologies (NASDAQ:NMTC) Could Be Quite Risky
Dec 18NeuroOne: Thin Film Electrodes For Diagnosis And Treatment Of Neurological Conditions
Nov 19Will NeuroOne Medical Technologies (NASDAQ:NMTC) Spend Its Cash Wisely?
Sep 04We're Not Very Worried About NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Rate
May 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$13m |
| Sep 30 2023 | US$990k | US$507k | -US$12m |
| Jun 30 2023 | n/a | n/a | -US$10m |
| Mar 31 2023 | n/a | n/a | -US$9m |
| Dec 31 2022 | n/a | n/a | -US$9m |
| Sep 30 2022 | US$1m | US$472k | -US$10m |
| Jun 30 2022 | n/a | n/a | -US$11m |
| Mar 31 2022 | n/a | n/a | -US$11m |
| Dec 31 2021 | n/a | n/a | -US$11m |
| Sep 30 2021 | US$2m | US$411k | -US$10m |
| Jun 30 2021 | n/a | n/a | -US$8m |
| Mar 31 2021 | n/a | n/a | -US$12m |
| Dec 31 2020 | n/a | n/a | -US$11m |
| Sep 30 2020 | US$1m | US$404k | -US$14m |
| Jun 30 2020 | n/a | n/a | -US$14m |
| Mar 31 2020 | n/a | n/a | -US$9m |
| Dec 31 2019 | n/a | n/a | -US$10m |
| Sep 30 2019 | US$558k | US$392k | -US$7m |
| Jun 30 2019 | n/a | n/a | -US$8m |
| Mar 31 2019 | n/a | n/a | -US$7m |
| Dec 31 2018 | n/a | n/a | -US$6m |
| Sep 30 2018 | US$417k | US$288k | -US$7m |
| Jun 30 2018 | n/a | n/a | -US$6m |
| Mar 31 2018 | n/a | n/a | -US$6m |
| Dec 31 2017 | US$496k | US$357k | -US$5m |
Compensation vs Market: Dave's total compensation ($USD989.56K) is above average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Dave's compensation has been consistent with company performance over the past year.
CEO
Dave Rosa (59 yo)
6.8yrs
Tenure
US$989,558
Compensation
Mr. David A. Rosa, also known as Dave, M.D., serves as an Independent Director of BioRestorative Therapies, Inc. since November 4, 2021. He serves as Director of BlinkTBI, Inc. since July 2023. He serves a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.8yrs | US$989.56k | 1.56% $ 456.0k | |
| Chief Financial Officer | 3.3yrs | US$390.16k | 0.44% $ 128.6k | |
| Chief Technology Officer | 5.1yrs | US$457.71k | 0.16% $ 46.6k | |
| Co-Founder | no data | US$260.85k | 1.11% $ 325.5k | |
| Chief Operating Officer | less than a year | no data | 0.29% $ 84.8k | |
| Vice President of Marketing | no data | no data | no data |
4.2yrs
Average Tenure
59.5yo
Average Age
Experienced Management: NMTC's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.8yrs | US$989.56k | 1.56% $ 456.0k | |
| Independent Director | 6.8yrs | US$120.49k | 0.32% $ 94.0k | |
| Independent Chairman of the Board | 6.8yrs | US$168.99k | 0.30% $ 87.9k | |
| Independent Director | 4.3yrs | US$118.99k | 0.23% $ 68.7k | |
| Member of Scientific Advisory Board | 2.9yrs | no data | no data | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 5.7yrs | no data | no data |
6.2yrs
Average Tenure
64yo
Average Age
Experienced Board: NMTC's board of directors are considered experienced (6.2 years average tenure).